Analysis of four circulating complexes of insulin-like growth factor binding proteins in human blood during aging
- Authors: Nedić O.1, Šunderić M.1, Gligorijević N.1, Malenković V.2, Miljuš G.1
-
Affiliations:
- INEP-Institute for the Application of Nuclear Energy
- Clinical-Medical Centre “Bežanijska Kosa”
- Issue: Vol 82, No 10 (2017)
- Pages: 1200-1206
- Section: Article
- URL: https://journal-vniispk.ru/0006-2979/article/view/151490
- DOI: https://doi.org/10.1134/S0006297917100133
- ID: 151490
Cite item
Abstract
The primary role of insulin-like growth factor binding proteins (IGFBPs) is to regulate availability of IGFs for interacting with receptors, but IGFBPs perform IGF-independent actions as well. The availability and activity of IGFBPs in the circulation is influenced primarily by their concentration and structural modifications, but possibly also by interaction with major plasma proteins such as transferrin, alpha-2-macroglobulin (α2M), and fibrinogen. Four types of circulating IGFBP complexes were examined in this study by immuno- and ligand-binding assays in adults of different age. The amounts of IGFBP-3/transferrin and IGFBP-1/fibrinogen complexes were similar in middle- and old-aged persons, whereas the amounts of IGFBP-1 (or -2)/α2M monomer complexes were lower in the old-aged group and negatively correlated with total IGFBP-1 (or -2) amounts in blood. In contrast to IGFBP-1, IGFBP-2 was present in significantly greater quantities in complexes with α2M dimer than α2M monomer in older individuals. IGFBP complexes did not bind 125I-labeled IGF-I in amounts detectable by ligand blotting. According to the results of this study, the quantities of IGFBP-1 and IGFBP-2, which interact with α2M, are age-dependent and, in the case of complexes with α2M monomer, they are negatively correlated with the total circulating levels of these two IGFBPs.
Keywords
About the authors
O. Nedić
INEP-Institute for the Application of Nuclear Energy
Author for correspondence.
Email: olgica@inep.co.rs
Serbia, Belgrade
M. Šunderić
INEP-Institute for the Application of Nuclear Energy
Email: olgica@inep.co.rs
Serbia, Belgrade
N. Gligorijević
INEP-Institute for the Application of Nuclear Energy
Email: olgica@inep.co.rs
Serbia, Belgrade
V. Malenković
Clinical-Medical Centre “Bežanijska Kosa”
Email: olgica@inep.co.rs
Serbia, Belgrade
G. Miljuš
INEP-Institute for the Application of Nuclear Energy
Email: olgica@inep.co.rs
Serbia, Belgrade
Supplementary files
